Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering
therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid …

Objectives Guidance recommends statin treatment in familial hypercholesterolaemia (FH) to
achieve at least a 50% reduction in low-density lipoprotein cholesterol (LDL-C). We …

Background The role of aspirin in cardiovascular primary prevention remains controversial.
Moreover, evidence for the potential benefits of aspirin in patients with high cardiovascular …

The present work focuses on the tapping test, which is a method that is commonly used in
the literature to assess dexterity, speed, and motor coordination by repeatedly moving …

To assess the determinants of lipid parameters in primary care patients without diagnosed
cardiovascular disease (CVD), a cross-sectional study was conducted during 2018–2019 …

Background: Primary prevention of cardiovascular disease (CVD) remains a major
challenge, especially in communities of low-and middle-income countries with poor medical …

La asociación entre patología cardiovascular y mala evolución de la infección por SARS-
CoV-2 resulta llamativa. Estudios publicados en diferentes países muestran que la …

Aims To study change over 8 years in cardiovascular risk, achievement of national guideline-
based treatment targets of lipids, blood pressure (BP) and smoking in primary prevention of …

Background The COVID-19 pandemic disrupted the continuing management of
cardiovascular disease (CVD) risk factors in the population. Socioeconomic status (SES) is a …

Aims Cardiovascular risk factor control is suboptimal in Europe, including Norway. The
present study examined the efficacy of a multimodal primary prevention intervention …